TrialLancet (London, England)2022

Combined nivolumab and ipilimumab with or without stereotactic body radiation therapy for advanced Merkel cell carcinoma: a randomised, open label, phase 2 trial.

Sungjune Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.